The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.

This publication has 9 references indexed in Scilit:

• Absence of Association Between Individual Thymidine Analogues or Nonnucleoside Analogues and Lipid Abnormalities in HIV-1–Infected Persons on Initial Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use
  AIDS, 2000
• Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
  New England Journal of Medicine, 1999
• Efavirenz: shifting the HAART paradigm in adult HIV-1 infection
  Expert Opinion on Investigational Drugs, 1999
• A Risk-Benefit Assessment of HIV Protease Inhibitors
  Drug Safety, 1999
• Antiretroviral Therapy for HIV Infection in 1998
  JAMA, 1998
• A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
  AIDS, 1998
• A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
  JAMA, 1998
• Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice
  Expert Opinion on Investigational Drugs, 1997